<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37773092</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1129-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>The journal of headache and pain</Title><ISOAbbreviation>J Headache Pain</ISOAbbreviation></Journal><ArticleTitle>COVID-19 vaccination-related headache showed two different clusters in the long-term course: a prospective multicenter follow-up study (COVA-Head Study).</ArticleTitle><Pagination><StartPage>132</StartPage><MedlinePgn>132</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">132</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s10194-023-01665-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although acute headache following COVID-19 vaccination is widely acknowledged, the long-term progression of these headaches remains poorly understood. Our objective was to identify various phenotypes of prolonged or worsened headaches associated with COVID-19 vaccination and document any changes in these phenotypes over an extended period. Additionally, we aimed to document the diverse headache presentations among patients with pre-existing primary headaches.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A multinational, prospective observational study was conducted to investigate prolonged or worsened headaches associated with COVID-19 vaccination. Questionnaires assessing COVID-19 vaccination-related headaches at three time points (initial visit, 3<sup>rd</sup> month follow-up, and 6th month follow-up) were developed for the study. Headache specialists/clinicians evaluated patients using these questionnaires in a prospective manner. Repeated K-means cluster analysis was performed to identify patient profiles with prolonged or worsened headaches related to COVID-19 vaccination.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 174 patients included in the study, there was a female-to-male ratio of 128 (73.6%) to 46 (26.4%). The mean age of the patient group was 45.2&#x2009;&#xb1;&#x2009;13.3&#xa0;years, and 107 patients (61.5%) had a pre-existing history of primary headaches. Through the analysis, two major clusters were identified based on headache characteristics at each visit. During the first visit (n&#x2009;=&#x2009;174), Cluster 1 primarily comprised patients with a history of primary headaches, frontal localization of pain, throbbing pain type, more severe headaches accompanied by symptoms such as nausea, phonophobia, photophobia, and osmophobia, and worsened by physical activity. In contrast, Cluster 2 consisted of patients with longer headache durations (over one month) and a stabbing/pressing quality of pain. Patients in Cluster 1 had a higher prevalence of migraine as the pre-existing primary headache disorder compared to Cluster 2 (90.48% vs. 68.18%, respectively; p&#x2009;=&#x2009;0.005).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The identification of two distinct phenotypes of prolonged or worsened headaches related to COVID-19 vaccination can provide valuable clinical insights. Having an awareness of the potential worsening of headaches following COVID-19 vaccination, particularly in patients with a primary headache disorder such as migraine, can help clinicians and headache experts anticipate and adjust their treatment strategies accordingly. This knowledge can aid in preplanning treatment modifications and optimize patient care.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer-Verlag Italia S.r.l., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Atalar</LastName><ForeName>Arife &#xc7;imen</ForeName><Initials>A&#xc7;</Initials><Identifier Source="ORCID">0000-0003-0328-9607</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Health Sciences University, Kanuni Sultan S&#xfc;leyman Education and Research Hospital, Istanbul, Turkey. cimenatalar@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acarl&#x131;</LastName><ForeName>Ay&#x15f;e Nur &#xd6;zda&#x11f;</ForeName><Initials>AN&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ermenek State Hospital, Karaman, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baykan</LastName><ForeName>Bet&#xfc;l</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Headache Center, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, EMAR Medical Center, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martelletti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolay</LastName><ForeName>Hayrunnisa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Medical Faculty, Department of Neurology and Algology, Gazi University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erta&#x15f;</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Headache Center, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekizo&#x11f;lu</LastName><ForeName>Esme</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Headache Center, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karada&#x15f;</LastName><ForeName>&#xd6;mer</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polat</LastName><ForeName>Burcu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Medicine, Department of Neurology, Istanbul Medipol University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gen&#xe7;dal</LastName><ForeName>I&#x15f;&#x131;l Yaz&#x131;c&#x131;</ForeName><Initials>IY</Initials><AffiliationInfo><Affiliation>Bakirkoy Prof. Dr. Mazhar Osman Training and Research Hospital for Psychiatric, Neurologic and Neurosurgical Diseases, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azorin</LastName><ForeName>David Garcia</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico Universitario de Valladolid, Headache Unit, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitsikostas</LastName><ForeName>Dimos</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>First Neurology Department, Medical School, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apostolakopoulou</LastName><ForeName>Loukia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>First Neurology Department, Medical School, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gen&#xe7;</LastName><ForeName>Hamit</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Health Sciences, Van Training and Research Hospital, Van, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dikmen</LastName><ForeName>P&#x131;nar Yal&#x131;nay</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>School of Medicine, Department of Neurology, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demirel</LastName><ForeName>Esra Ac&#x131;man</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>B&#xfc;lent Ecevit University Neurology Department, Zonguldak, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayd&#x131;nlar</LastName><ForeName>Elif Ilgaz</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>School of Medicine, Department of Neurology, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;z&#xfc;bat&#x131;k-Celik</LastName><ForeName>Rabia G&#xf6;k&#xe7;en</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Bakirkoy Prof. Dr. Mazhar Osman Training and Research Hospital for Psychiatric, Neurologic and Neurosurgical Diseases, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafiyev</LastName><ForeName>Javid</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta&#x15f;delen</LastName><ForeName>Bahar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Medical Informatic, Mersin University School of Medicine, Mersin, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zge</LastName><ForeName>Aynur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Faculty, Department of Neurology, Mersin University, Mersin, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Headache Pain</MedlineTA><NlmUniqueID>100940562</NlmUniqueID><ISSNLinking>1129-2369</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008881" MajorTopicYN="Y">Migraine Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">Headache</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Primary headache</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>11</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37773092</ArticleId><ArticleId IdType="pmc">PMC10541695</ArticleId><ArticleId IdType="doi">10.1186/s10194-023-01665-3</ArticleId><ArticleId IdType="pii">10.1186/s10194-023-01665-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sekiguchi K, Watanabe N, Miyazaki N, et al. Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study. Cephalalgia. 2022;42:266&#x2013;272. doi: 10.1177/03331024211038654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211038654</ArticleId><ArticleId IdType="pmc">PMC8988452</ArticleId><ArticleId IdType="pubmed">34407651</ArticleId></ArticleIdList></Reference><Reference><Citation>- World Health Organization. Draft landscape of COVID-19 candidate vaccines https://www.who.int/publications/ m/item/draft-landscape-of-covid-19-candidate-vaccines (23 January 2023, accessed 02 February 2023.</Citation></Reference><Reference><Citation>Garcia-Azorin D, Baykan B, Beghi E, et al. Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports. Cephalalgia. 2022;42:1207&#x2013;1217. doi: 10.1177/03331024221099231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024221099231</ArticleId><ArticleId IdType="pubmed">35514199</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, van den Hoek TC, Bolay H, et al. Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review. Cephalalgia. 2023;43:3331024221131337. doi: 10.1177/03331024221131337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024221131337</ArticleId><ArticleId IdType="pubmed">36606562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur RJ, Dutta S, Bhardwaj P, et al. Adverse events reported from COVID-19 vaccine trials: A systematic review. Indian J Clin Biochem. 2021;36:427&#x2013;439. doi: 10.1007/s12291-021-00968-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12291-021-00968-z</ArticleId><ArticleId IdType="pmc">PMC7997788</ArticleId><ArticleId IdType="pubmed">33814753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekizoglu E, Gezegen H, Yal&#x131;nay Dikmen P, et al. The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic. Cephalalgia. 2022;42:366&#x2013;375. doi: 10.1177/03331024211042390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211042390</ArticleId><ArticleId IdType="pmc">PMC8988457</ArticleId><ArticleId IdType="pubmed">34510919</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Azor&#xed;n D, Do TP, Gantenbein AR, et al. Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. J Headache Pain. 2021;22(1):108. doi: 10.1186/s10194-021-01324-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01324-5</ArticleId><ArticleId IdType="pmc">PMC8446734</ArticleId><ArticleId IdType="pubmed">34535076</ArticleId></ArticleIdList></Reference><Reference><Citation>- Vaccine Adverse Event Reporting System (VAERS). VAERS Data Sets. Available on: https://vaers.hhs.gov/data.html Accessed on February 2, 2023).</Citation></Reference><Reference><Citation>Martelletti P. COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache. Int J Environ Res Public Health. 2023;20:3914. doi: 10.3390/ijerph20053914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20053914</ArticleId><ArticleId IdType="pmc">PMC10002133</ArticleId><ArticleId IdType="pubmed">36900925</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen MP. Pain assessment in clinical trials. In: Wittink H, Carr D, editors. Pain Management: Evidence, Outcomes and Quality of Life in Pain Treatment. Amsterdam: Elsevier; 2008. pp. 57&#x2013;58.</Citation></Reference><Reference><Citation>Polat B, &#xd6;zge A, Helvac&#x131; Y&#x131;lmaz N, et al. Validity and reliability of the Turkish version of the mig-scog scale in migraine patients. Neurological Sciences and Neurophysiology. 2020;37:29&#x2013;35. doi: 10.4103/2636-865X.283928.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2636-865X.283928</ArticleId></ArticleIdList></Reference><Reference><Citation>- Headache Classification Committee of the International Headache Society (IHS) (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38: 1&#x2013;211.&#xa0;10.1177/0333102417738202</Citation><ArticleIdList><ArticleId IdType="pubmed">29368949</ArticleId></ArticleIdList></Reference><Reference><Citation>- TIBCO Software Inc. (2018). Statistica (data analysis software system), version 13. http://tibco.com)</Citation></Reference><Reference><Citation>Cocores AN, Goadsby PJ, Monteith TS. Post-vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System. Headache. 2023;63:275&#x2013;282. doi: 10.1111/head.14458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14458</ArticleId><ArticleId IdType="pubmed">36651626</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;bel CH, Heinze A, Karstedt S, et al. Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2. with the BNT162b2 mRNA vaccine: a multicentre observational cohort study. Brain Commun. 2021;3:fcab169. doi: 10.1093/braincomms/fcab169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab169</ArticleId><ArticleId IdType="pmc">PMC8344581</ArticleId><ArticleId IdType="pubmed">34405142</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccardi G, Schiano di Cola F, Di Cesare M, et al. Post COVID-19 vaccination headache: A clinical and epidemiological evaluation. Front Pain Res (Lausanne) 2022;3:994140. doi: 10.3389/fpain.2022.994140.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpain.2022.994140</ArticleId><ArticleId IdType="pmc">PMC9679518</ArticleId><ArticleId IdType="pubmed">36425358</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdy R, Khedr D, Yacoub O, et al. Epidemiological aspects of headache after different types of COVID-19 vaccines: An online survey. Headache. 2022;62:1046&#x2013;1052. doi: 10.1111/head.14374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14374</ArticleId><ArticleId IdType="pmc">PMC9538602</ArticleId><ArticleId IdType="pubmed">36005277</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;bel CH, Heinze A, Karstedt S, et al. Headache attributed to vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) vaccine: A multicenter observational cohort study. Pain Ther. 2021;10:1309&#x2013;1330. doi: 10.1007/s40122-021-00296-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40122-021-00296-3</ArticleId><ArticleId IdType="pmc">PMC8314854</ArticleId><ArticleId IdType="pubmed">34313952</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestro M, Tessitore A, Orologio I, et al. Headache Worsening after COVID-19 Vaccination: An Online Questionnaire-Based Study on 841 Patients with Migraine. J Clin Med. 2021;10:5914. doi: 10.3390/jcm10245914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245914</ArticleId><ArticleId IdType="pmc">PMC8708794</ArticleId><ArticleId IdType="pubmed">34945208</ArticleId></ArticleIdList></Reference><Reference><Citation>Naitlho A, Lahlou W, Bourial A, et al. A Rare Case of Henoch-Sch&#xf6;nlein Purpura Following a COVID-19 Vaccine-Case Report. SN Compr Clin Med. 2021;3:2618&#x2013;2621. doi: 10.1007/s42399-021-01025-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-01025-9</ArticleId><ArticleId IdType="pmc">PMC8425851</ArticleId><ArticleId IdType="pubmed">34518812</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol. 2011;12:509&#x2013;517. doi: 10.1038/ni.2039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2039</ArticleId><ArticleId IdType="pmc">PMC3253344</ArticleId><ArticleId IdType="pubmed">21739679</ArticleId></ArticleIdList></Reference><Reference><Citation>Castaldo M, Waliszewska-Pros&#xf3;&#x142; M, Koutsokera M, et al. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. J Headache Pain. 2022;31:41. doi: 10.1186/s10194-022-01400-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01400-4</ArticleId><ArticleId IdType="pmc">PMC8969402</ArticleId><ArticleId IdType="pubmed">35361131</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelletti P, Bentivegna E, Spuntarelli V, et al. Long-COVID Headache. SN Compr. Clin Med. 2021;2021(3):1704&#x2013;1706. doi: 10.1007/s42399-021-00964-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-00964-7</ArticleId><ArticleId IdType="pmc">PMC8136258</ArticleId><ArticleId IdType="pubmed">34036244</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Bentivegna E, Cho SJ, et al. Long COVID headache. J Headache Pain. 2022;1:93. doi: 10.1186/s10194-022-01450-8.PMID:35915417;PMCID:PMC9340759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8.PMID:35915417;PMCID:PMC9340759</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>